These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 2645712

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Incidence of posttransplant diabetes mellitus in kidney transplant recipients immunosuppressed with sirolimus in combination with cyclosporine.
    Romagnoli J, Citterio F, Nanni G, Favi E, Tondolo V, Spagnoletti G, Salerno MP, Castagneto M.
    Transplant Proc; 2006 May; 38(4):1034-6. PubMed ID: 16757255
    [Abstract] [Full Text] [Related]

  • 3. Impact of posttransplant diabetes mellitus on graft function in autosomal dominant polycystic kidney disease patients after kidney transplantation.
    Pietrzak-Nowacka M, Safranow K, Dziewanowski K, Debska-Slizień A, Głyda M, Gołembiewska E, Jankowska M, Nowosiad M, Rutkowski B, Ciechanowski K.
    Ann Acad Med Stetin; 2008 May; 54(1):41-8. PubMed ID: 19127808
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Posttransplant diabetes mellitus: incidence and risk factors.
    Mazali FC, Lalli CA, Alves-Filho G, Mazzali M.
    Transplant Proc; 2008 Apr; 40(3):764-6. PubMed ID: 18455010
    [Abstract] [Full Text] [Related]

  • 6. Posttransplant diabetes mellitus in renal allograft recipients: A prospective multicenter study at 2 years.
    Marcén R, Morales JM, del Castillo D, Campistol JM, Serón D, Valdés F, Anaya F, Andrés A, Arias M, Bustamante J, Capdevila L, Escuin F, Gil-Vernet S, Gonzalez-Molina M, Lampreave I, Oppenheimer F, Pallardó L, Spanish Renal Forum.
    Transplant Proc; 2006 Dec; 38(10):3530-2. PubMed ID: 17175323
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. The impact of cyclosporine and combination immunosuppression on the incidence of posttransplant diabetes in renal allograft recipients.
    Boudreaux JP, McHugh L, Canafax DM, Ascher N, Sutherland DE, Payne W, Simmons RL, Najarian JS, Fryd DS.
    Transplantation; 1987 Sep; 44(3):376-81. PubMed ID: 3307061
    [Abstract] [Full Text] [Related]

  • 9. Post transplant diabetes mellitus in live related renal allograft recipients: a single centre experience.
    Saxena S, Dash SC, Guleria S, Mittal R, Agarwal SK, Tiwari SC, Mehta SN.
    J Assoc Physicians India; 1996 Jul; 44(7):472, 477-9. PubMed ID: 9282609
    [Abstract] [Full Text] [Related]

  • 10. Effect of early cyclosporine levels on kidney allograft rejection.
    Johnson EM, Canafax DM, Gillingham KJ, Humar A, Pandian K, Kerr SR, Najarian JS, Matas AJ.
    Clin Transplant; 1997 Dec; 11(6):552-7. PubMed ID: 9408683
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Incidence and risk factors of clinical characteristics, tacrolimus pharmacokinetics, and related genomic polymorphisms for posttransplant diabetes mellitus in the early stage of renal transplant recipients.
    Numakura K, Satoh S, Tsuchiya N, Horikawa Y, Inoue T, Kakinuma H, Togashi H, Matsuura S, Tada H, Suzuki T, Habuchi T.
    Transplant Proc; 2005 May; 37(4):1865-7. PubMed ID: 15919487
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Conversion from tacrolimus to cyclosporine could improve control of posttransplant diabetes mellitus after renal transplantation.
    Ramos-Cebrián M, Torregrosa JV, Gutiérrez-Dalmau A, Oppenheimer F, Campistol JM.
    Transplant Proc; 2007 Sep; 39(7):2251-3. PubMed ID: 17889154
    [Abstract] [Full Text] [Related]

  • 15. Risk factors and incidence of posttransplant diabetes mellitus in renal transplant recipients.
    Foo SM, Wong HS, Morad Z.
    Transplant Proc; 2004 Sep; 36(7):2139-40. PubMed ID: 15518776
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Is HLA-DR6 a protective factor against posttransplantation diabetes mellitus?
    Nafar M, Pour-Reza-Gholi F, Amouzegar A, Einollahi B, Firouzan A, Hemati K, Amjadi H.
    Transplant Proc; 2005 Sep; 37(7):3098-100. PubMed ID: 16213318
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Clinicoepidemiologic study of posttransplant diabetes after living-donor renal transplant.
    Elmagd MM, Bakr MA, Metwally AH, Wahab AM.
    Exp Clin Transplant; 2008 Mar; 6(1):42-7. PubMed ID: 18405244
    [Abstract] [Full Text] [Related]

  • 20. De novo cancer in cyclosporine-treated and non-cyclosporine-treated adult primary renal allograft recipients.
    Gruber SA, Gillingham K, Sothern RB, Stephanian E, Matas AJ, Dunn DL.
    Clin Transplant; 1994 Aug; 8(4):388-95. PubMed ID: 7949545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.